Rita Abi Rached | Neuropharmacology | Best Researcher Award

Published on by Neuroscientists

Dr. Rita Abi Rached | Neuropharmacology | Best Researcher Award

Dr. Rita Abi Rached, University of Cagliari, Italy.

Rita Joseph Abi Rached has built a remarkable career at the intersection of food chemistry, biochemistry, and sustainability. From her foundational academic journey to her current research in agri-food by-product valorization, she has continuously sought innovative solutions to environmental and health-related challenges. Her expertise spans industry collaborations, cutting-edge research, and impactful scientific contributions, making her a leading figure in sustainable food science.

Profile

Google Scholar

✨ Early Academic Pursuits – A Passion for Science ✨

From an early age, Rita Joseph Abi Rached demonstrated an innate curiosity for the sciences, particularly in the fields of biochemistry and food chemistry. She embarked on her academic journey with a Bachelor’s degree in Biochemistry from Saint Joseph University of Beirut in 2017, where she cultivated a strong foundation in molecular sciences. Her passion for the chemical intricacies of food systems led her to pursue a Master’s degree in Food Chemistry in 2019, further refining her expertise in the biochemical properties of agro-food products. This academic dedication ultimately culminated in a Double Ph.D. in Life, Environmental, and Pharmaceutical Sciences from the University of Cagliari and Saint Joseph University of Beirut in 2024, marking a significant milestone in her scholarly endeavors.

🌱 Professional Endeavors – Bridging Academia and Industry 🌱

With an unwavering commitment to research, Rita transitioned from academia to professional scientific exploration. Her early training included hands-on experiences at Château Ksara, where she assessed grape phenolic maturity, and at Libby’s, where she gained insights into quality control and microbiological analyses. Further strengthening her industrial expertise, she worked as a lab researcher and research assistant at Saint Joseph University, refining her skills in polyphenol analysis and microbiological assessments. These experiences not only expanded her technical competencies but also paved the way for her role as a dedicated researcher at the University of Cagliari, where she currently investigates sustainable approaches to agri-food by-product valorization.

🤝 Contributions and Research Focus – Innovating for a Sustainable Future 🤝

Rita’s research is deeply rooted in sustainability and the innovative utilization of agricultural and industrial biomasses. Her current work revolves around the valorization of agro-industrial by-products, transforming waste into functional bioactive compounds for health and agriculture. She has actively contributed to groundbreaking projects such as BESTMEDGRAPE, which applied nanotechnological strategies to enhance Mediterranean grape derivatives, and MEDLENTISK, an Erasmus+ initiative that explored best practices for mastic tree fixed oil. Additionally, she played a pivotal role in TECNOCOVID, a project leveraging natural bioactives and nanotechnologies to combat COVID-19. Her most recent endeavor, NUTRINNOVA, focuses on utilizing nutriosomes derived from agro-industrial waste to mitigate dysbiosis, oxidative stress, and cognitive decline, further establishing her as a pioneer in sustainable food research.

🏆 Accolades and Recognition – A Scholar’s Journey 🏆

Throughout her career, Rita has garnered significant recognition for her impactful contributions to scientific research. Her work has been widely cited, with a citation index of 72 and an h-index of 4, reflecting her influence in the academic community. These achievements underscore the relevance of her studies in the fields of food science, biotechnology, and environmental sustainability. Her research outputs continue to inspire new approaches to the responsible and efficient use of natural resources, positioning her as a respected voice in her domain.

🔍 Impact and Influence – Shaping the Scientific Landscape 🔍

As an advocate for innovative and sustainable research, Rita’s work has transcended the boundaries of traditional food science, merging interdisciplinary methodologies to address global challenges. By focusing on agri-food waste valorization, she has provided meaningful insights into reducing environmental impact while enhancing the nutritional and therapeutic value of food by-products. Her collaborations with industry leaders and academic institutions have reinforced her reputation as a key contributor to cutting-edge scientific advancements.

 

Publication

  • Title: Entrapment of Citrus limon var. pompia Essential Oil or Pure Citral in Liposomes Tailored as Mouthwash for the Treatment of Oral Cavity Diseases
    Author(s): L Palmas, M Aroffu, GL Petretto, E Escribano-Ferrer, O Díez-Sales, …
    Year: 2020

 

  • Title: Extraction, Characterization and Incorporation of Hypericum scruglii Extract in Ad Hoc Formulated Phospholipid Vesicles Designed for the Treatment of Skin
    Author(s): M Allaw, M Manconi, M Aroffu, F Marongiu, M Porceddu, G Bacchetta, …
    Year: 2020

 

  • Title: Optimization of Polyphenols Extraction from Purple Corn Cobs Using ß-Cyclodextrin as a Green Solvent
    Author(s): HN Rajha, S Khabbaz, R Abi Rached, E Debs, RG Maroun, N Louka
    Year: 2020

 

  • Title: From Grape By-Products to Enriched Yogurt Containing Pomace Extract Loaded in Nanotechnological Nutriosomes Tailored for Promoting Gastro-Intestinal Wellness
    Author(s): I Castangia, F Fulgheri, FJ Leyva-Jimenez, ME Alañón, ML Cádiz-Gurrea, …
    Year: 2023

 

  • Title: From Field to Waste Valorization: A Preliminary Study Exploring the Impact of the Wine Supply Chain on the Phenolic Profile of Three Sardinian Pomace Extracts
    Author(s): I Castangia, M Aroffu, F Fulgheri, R Abi Rached, F Corrias, G Sarais, …
    Year: 2024

 

  • Title: Innovation in Cannon Puffing Technology for the Homogenization of Bulk Treatment: Half‐Popped Purple Corn, a New Healthy Snack
    Author(s): HN Rajha, E Debs, R Abi Rached, K El Khoury, M Al‐Kazzi, R Mrad, …
    Year: 2021

 

  • Title: Exploring the Efficacy and Industrial Potential of Polyphenol Products from Grapes and Their By-Products
    Author(s): R Abi Rached, M Perra, ML Manca, HN Rajha, N Louka, RG Maroun, …
    Year: 2024

 

  • Title: A Preliminary Investigation on Hydrogel Disks Imbibed with Enriched Transfersomes as a Promising Tool to Promote the Cutaneous Deposition of Vaccine Antigens
    Author(s): M Aroffu, R Abi Rached, I Castangia, P Italiani, L D’Apice, …
    Year: 2024

 

  • Title: Preliminary Evaluation of the In Vitro and In Vivo Efficacy of a Novel Nanovesicle-Doped Nanoemulsion Co-Loading Artemisinin and Quercetin as a Promising Strategy to Improve …
    Author(s): F Fulgheri, M Ramírez, L Román-Álamo, P Gasco, M Manconi, M Aroffu, …
    Year: 2025

 

  • Title: Clinical Trial to Evaluate the Effect of Grape Seed Extract-Loaded Hyalurosomes on Skin Wellness
    Author(s): RA Rached, M Habre, Y Salem, J Khodeir, M Allaw, I Castangia, …
    Year: 2025

 

🔗 Conclusion 🔗

With an unwavering passion for science and an unrelenting drive for discovery, Rita Joseph Abi Rached stands as a beacon of innovation, inspiring future generations to embrace sustainability, research, and the transformative power of science. Her legacy in food science and biochemistry will continue to shape the future of sustainable research, leaving a lasting impact on both academia and industry.

Daša Zupančič | Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Daša Zupančič | Cellular Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Daša Zupančič, Faculty of Medicine, University of Ljubljana, Slovenia.

Daša Zupančič is a distinguished academic and researcher specializing in cell biology, urothelial pathology, and medical education. Her extensive contributions to scientific research, particularly in the field of urothelial repair and cancer transformation, have earned her recognition, including the EMBO award. She has played a crucial role in mentoring and teaching, guiding future generations of researchers and medical professionals.

Profile

Orcid

✨ Early Academic Pursuits ✨

Daša Zupančič embarked on her academic journey with an unwavering passion for cell biology and medicine. She earned her Master’s degree in 2002 from the University of Ljubljana, Faculty of Medicine, where she meticulously explored cellular and molecular biological changes in the rat bladder urothelium following cyclophosphamide exposure. This formative research laid the foundation for her Ph.D., which she successfully completed in 2006, investigating the protective role of melatonin in urothelial injury and repair. Her dedication to advancing biomedical knowledge was evident from the very beginning of her scholarly career.

🎓 Professional Endeavors 🎓

Since 2006, Daša Zupančič has been an esteemed Associate Professor at the University of Ljubljana, Faculty of Medicine, Institute of Cell Biology. Prior to this, she gained valuable experience as a Young Researcher and Teaching Assistant from 1999 to 2006. Her extensive expertise and commitment to education have made her an integral part of the institution, where she continuously fosters scientific curiosity and excellence among students and colleagues alike.

🎡 Contributions and Research Focus 🎡

Throughout her career, Daša Zupančič has dedicated her research to understanding cellular mechanisms in urothelial biology and pathology. Her investigations into cyclophosphamide-induced urothelial injury, melatonin’s protective effects, and retinoid signaling pathways in urothelial cancer transformation have provided valuable insights into cellular repair processes. Her work extends beyond laboratory research, influencing the medical community’s approach to urothelial diseases and potential therapeutic advancements.

🏆 Accolades and Recognition 🏆

Her exceptional contributions to biomedical research have been recognized on multiple platforms. In 2017, she was honored with the prestigious EMBO award for her short-term scholarship project on the role of the retinoid signaling pathway in urothelial cancer transformation. This recognition underscores her significant impact on the scientific community and highlights her pioneering approach to understanding cancer pathophysiology.

👨‍🎓 Impact and Influence 👨‍🎓

A dedicated mentor, Daša Zupančič has guided numerous students towards academic excellence. Between 2014 and 2025, she has successfully mentored four master’s students and is currently supervising two more. In addition, she has overseen the research endeavors of four Ph.D. candidates, with one having successfully defended their dissertation in 2023 and another expected to graduate in 2025. Her mentorship has shaped the next generation of biomedical researchers, fostering a culture of rigorous inquiry and scientific discovery.

📚 Legacy and Future Contributions 📚

Beyond her research, Daša Zupančič plays a pivotal role in academia through her extensive teaching engagements. Since 2000, she has been a cornerstone of education at the University of Ljubljana, contributing to multiple faculties, including Medicine, Biotechnical Sciences, Health Sciences, and Pharmacy. She teaches a range of graduate and doctoral courses, covering essential subjects such as Medical Cell Biology, Immunology, and Research in Medicine. Her dedication to education ensures that her knowledge and expertise continue to shape the minds of aspiring medical professionals and researchers for years to come.

Publication

  • Vitamin A‐Enriched Diet Increases Urothelial Cell Proliferation by Upregulating Itga3 and Areg After Cyclophosphamide‐Induced Injury in Mice
    Authors: Brina Dragar, Simona Kranjc Brezar, Maja Čemažar, Tanja Jesenko, Rok Romih, Mateja Erdani Kreft, Tadeja Kuret, Daša Zupančič
    Year: 2025

 

  • Selective Targeting of Lectins and Their Macropinocytosis in Urothelial Tumours: Translation from in vitro to ex vivo
    Authors: Nataša Resnik, Tanja Višnjar, Tomaž Smrkolj, Mateja Erdani Kreft, Rok Romih, Daša Zupančič
    Year: 2023

 

  • Nanodiamonds as Possible Tools for Improved Management of Bladder Cancer and Bacterial Cystitis
    Authors: Daša Zupančič, Peter Veranič
    Year: 2022

 

  • Transmission Electron Microscopy Demonstration of Reduced Endothelial Glycocalyx in Severe Preeclampsia
    Authors: Mugerli S, Zupančič D, Rok Romih, Lučovnik M
    Year: 2022

 

  • Vitamin A and Retinoids in Bladder Cancer Chemoprevention and Treatment: A Narrative Review of Current Evidence, Challenges and Future Prospects
    Authors: Larisa Tratnjek, Jera Jeruc, Rok Romih, Daša Zupančič
    Year: 2021

 

  • Immunohistochemistry as a Paramount Tool in Research of Normal Urothelium, Bladder Cancer and Bladder Pain Syndrome
    Authors: Daša Zupančič, Rok Romih
    Year: 2021

 

  • Combined Lectin- and Immuno-Histochemistry (CLIH) for Applications in Cell Biology and Cancer Diagnosis: Analysis of Human Urothelial Carcinomas
    Authors: Daša Zupančič
    Year: 2020

 

  • Vitamin A Rich Diet Diminishes Early Urothelial Carcinogenesis by Altering Retinoic Acid Signaling
    Authors: Daša Zupančič, Jelena Korać-Prlić, Mateja Erdani Kreft, Lucija Franković, Katarina Vilović, Jera Jeruc, Rok Romih, Janoš Terzić
    Year: 2020

 

  • Lectins as Possible Tools for Improved Urinary Bladder Cancer Management
    Authors: Daša Zupančič
    Year: 2019

 

  • Co-Culturing Porcine Normal Urothelial Cells, Urinary Bladder Fibroblasts and Smooth Muscle Cells for Tissue Engineering Research
    Authors: Daša Zupančič
    Year: 2018

 

🌟 Conclusion 🌟

With a career dedicated to pioneering research, impactful mentorship, and transformative education, Daša Zupančič continues to leave a lasting legacy in the scientific and academic communities. Her work not only enhances understanding of urothelial biology but also inspires innovation and discovery among young scientists. As she continues her academic and research endeavors, her influence on the field will undoubtedly grow, shaping the future of biomedical sciences.

 

Fahriye Çoban | Neurorehabilitation | Best Researcher Award

Published on by Neuroscientists

Mrs. Fahriye Çoban | Neurorehabilitation | Best Researcher Award

Mrs. Fahriye Çoban,  European University of Lefke, Cyprus.

Fahriye Çoban, PT, MSc, is a dedicated physiotherapist and academic from the Turkish Republic of Northern Cyprus. She earned her bachelor’s and master’s degrees from the European University of Lefke and is set to complete her Ph.D. in May 2025. With a strong foundation in neurological rehabilitation, preventive rehabilitation, and physical activity, she has built a distinguished career in academia. She has served as a lecturer at the American University of Cyprus and later at the European University of Lefke, where she continues to shape the next generation of physiotherapists. Her research and leadership as a board member of the Cyprus Turkish Physical Activity Association highlight her commitment to advancing the field.

Profile

orcid

 

Early Academic Pursuits 🎓

Born in 1995 in the Turkish Republic of Northern Cyprus, Fahriye Çoban embarked on her academic journey with a deep passion for physiotherapy and rehabilitation. She pursued her undergraduate studies at the European University of Lefke, graduating in 2017 with a degree in physiotherapy. Her dedication to advancing her knowledge led her to complete a master’s degree in 2019. Committed to continuous learning and research, she is set to obtain her Ph.D. from the same institution in May 2025, further cementing her expertise in the field.

Professional Endeavors 🏥

Fahriye Çoban’s career in academia began in 2020 when she joined the American University of Cyprus as a lecturer. Her commitment to research and education then led her back to the European University of Lefke, where she served as a research assistant in 2021. Since 2022, she has been a lecturer at the university, shaping the future of physiotherapy students and contributing to the academic community through her teachings and mentorship.

Contributions and Research Focus 🔬

Specializing in neurological rehabilitation, preventive rehabilitation, and physical activity, Fahriye Çoban’s research is centered on improving the quality of life for individuals affected by neurological disorders and promoting preventive strategies to enhance physical well-being. Her work delves into innovative rehabilitation techniques, ensuring patients receive evidence-based interventions tailored to their needs. Her studies not only contribute to academic literature but also have practical applications in clinical settings, reinforcing her role as a pioneer in the field.

Accolades and Recognition 🏆

Fahriye Çoban’s expertise and dedication have not gone unnoticed. Since 2023, she has been serving as a board member of the Cyprus Turkish Physical Activity Association, a testament to her influence and leadership in promoting physical activity and rehabilitation initiatives within the community. Her contributions to physiotherapy education and research have earned her recognition among peers, students, and professionals alike.

Impact and Influence 🌍

Through her teaching, research, and professional engagements, Fahriye Çoban has made a lasting impact on both the academic and healthcare sectors. Her work in neurological and preventive rehabilitation has inspired students and practitioners to adopt holistic and innovative approaches to patient care. She actively participates in knowledge dissemination, ensuring that her research findings contribute to improving rehabilitation practices and patient outcomes.

Legacy and Future Contributions 🔮

As she prepares to complete her Ph.D., Fahriye Çoban continues to push the boundaries of physiotherapy research. Her future endeavors aim to integrate emerging technologies, advanced rehabilitation techniques, and interdisciplinary collaborations into physiotherapy. She envisions a future where physiotherapy plays a more proactive role in healthcare, emphasizing prevention and long-term well-being. With her passion and expertise, she is poised to leave a remarkable legacy in the field, inspiring future generations of physiotherapists to embrace innovation and patient-centered care.

Publication

  • Motor learning-based clinical Pilates training for Parkinson’s disease rehabilitation: A parallel group, randomised controlled trial with 3-month follow-up

    • Authors: Fahriye Coban, Beliz Belgen Kaygisiz, Ferda Selcuk
    • Year: 2025

 

  • Enhancing the Motor Learning: Clinical Pilates Training for Parkinson’s Disease: Study Protocol for a Randomised Controlled Trial

    • Authors: Fahriye Çoban, Beliz Belgen Kaygısız
    • Year: 2024

 

  • Effect of clinical Pilates training on balance and postural control in patients with Parkinson’s disease: a randomized controlled trial

    • Authors: Fahriye Çoban, Beliz Belgen Kaygısız, Ferda Selcuk
    • Year: 2021

 

  • The effect of clinical Pilates-based physiotherapy program for a Stiff Person Syndrome patient: A case report

    • Authors: Beliz Belgen Kaygisiz, Fahriye Çoban, Ferda Selcuk
    • Year: 2021

 

  • Determination of exercise habits, physical activity level and anxiety level of postmenopausal women during COVID-19 pandemic

    • Authors: Beliz Belgen Kaygısız, Zehra Güçhan Topcu, Aydın Meriç, Havva Gözgen, Fahriye Çoban
    • Year: 2020

 

Conclusion 🔗

Fahriye Çoban’s journey reflects a profound dedication to physiotherapy, education, and research. Through her expertise in rehabilitation sciences, she has contributed significantly to patient care, academic development, and professional organizations. As she prepares to complete her Ph.D., her work will continue to influence rehabilitation techniques and physical activity promotion. With her unwavering passion and commitment, she is set to leave a lasting legacy in the field, inspiring future healthcare professionals to innovate and improve physiotherapy practices worldwide.

Pongrama Ramasoota | Molecular and Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Pongrama Ramasoota | Molecular and Cellular Neuroscience | Best Researcher Award

Prof. Dr. Pongrama Ramasoota, Mahidol University, Thailand.

Dr. Pongrama Ramasoota is a distinguished professor and researcher specializing in antibody research and virology at the Centre of Excellence for Antibody Research (CEAR), Mahidol University, Thailand. With a strong academic foundation in veterinary medicine, public health, and microbiology, he has dedicated his career to developing therapeutic and diagnostic monoclonal antibodies against viruses such as Dengue, Rabies, Foot and Mouth Disease, and Influenza. His contributions extend beyond infectious disease research, as he has also explored anti-aging supplements for humans and pets. Recognized with numerous national and international awards, his research has significantly impacted medical biotechnology, earning him a reputation as a leading scientist in his field.

 

Profile

Scopus

 

🎓 Early Academic Pursuits

Pongrama Ramasoota’s journey into the world of microbiology and antibody research began with a solid foundation in veterinary medicine. He earned his Doctor of Veterinary Medicine from Kasetsart University, where his fascination with infectious diseases and immunology took root. His academic pursuits led him to Mahidol University, where he obtained a Master of Public Health, further broadening his expertise in disease prevention and control. Driven by a passion for scientific exploration, he pursued a Master of Science and Ph.D. in Microbiology at the prestigious Swedish University of Agricultural Sciences in Uppsala, Sweden. These formative years were instrumental in shaping his career as a leading researcher in antibody development and disease management.

🏥 Professional Endeavors

As a distinguished professor at the Centre of Excellence for Antibody Research (CEAR) within the Faculty of Tropical Medicine, Mahidol University, Dr. Ramasoota has dedicated his career to advancing the field of immunotherapy. His research primarily focuses on developing neutralizing monoclonal antibodies to combat viral threats such as Dengue and Rabies. Over the years, he has led groundbreaking projects aimed at creating effective therapeutic and diagnostic solutions. His expertise has also extended beyond academia, as he collaborates with industry leaders to translate research into practical applications that benefit global health.

🦠 Contributions and Research Focus

Dr. Ramasoota’s contributions to medical research are vast and impactful. His work on neutralizing human monoclonal antibodies against Dengue and Rabies viruses has paved the way for potential life-saving treatments. His research extends to diagnostic monoclonal antibodies for detecting Foot and Mouth Disease Virus (FMDV) and Influenza, significantly enhancing disease surveillance. Beyond infectious diseases, he has also ventured into anti-aging research, developing natural supplements to promote longevity in both humans and pets. His relentless pursuit of innovation continues to drive advancements in virology, immunotherapy, and biotechnology.

🏆 Accolades and Recognition

Dr. Ramasoota’s contributions to science have been recognized with numerous prestigious awards. He was honored as Thailand’s Outstanding Researcher in 2020 and named Thailand’s Outstanding Veterinarian in 2016. His innovative work earned him multiple Outstanding Research and Invention Awards from the National Research Council of Thailand between 2008 and 2016. He has also received international recognition, including a gold medal from the 2014 Taipei Invention & Techno Mart and awards from the Korea Invention Association and the International Federation of Inventors’ Associations. These accolades underscore his influence as a pioneer in antibody research and biotechnology.

🌍 Impact and Influence

With an H-index of 18 and over 1,038 citations on Scopus, Dr. Ramasoota’s research has significantly influenced the scientific community. His findings have been instrumental in shaping new treatment strategies for viral diseases, providing hope for better therapeutic interventions. Collaborating with industry leaders such as Advy Chemical (India) and Thai-Naoka (Thailand), he has helped bridge the gap between research and real-world applications. His contributions to diagnostic tools and monoclonal antibody therapies continue to shape the future of virology and medical biotechnology.

📚 Legacy and Future Contributions

Beyond his research endeavors, Dr. Ramasoota has authored books that highlight his expertise in environmental management and anti-aging technologies. His book Hallmarks of Aging, Technology and Innovation for Anti-Aging explores groundbreaking advancements in longevity research, demonstrating his commitment to improving human health across various dimensions. As he continues to innovate, his legacy as a leading researcher in antibody development and viral immunotherapy will inspire future generations of scientists. His ongoing efforts to combat infectious diseases and promote healthier aging promise a lasting impact on global health and biotechnology.

Publication

  1. Title: Development of novel canine phage display-derived neutralizing monoclonal antibody fragments against rabies virus from immunized dogs
    Authors: A. Chorpunkul, U. Boonyuen, K. Limkittikul, P. Lekcharoensuk, P. Ramasoota
    Year: 2024

 

  1. Title: Characterization of Vibrio parahaemolyticus isolated from clinical specimens and oysters in Thailand
    Authors: N. Tewawong, S. Kowaboot, S. Kengkarn, P. Ramasoota, O. Suthienkul
    Year: 2024

 

  1. Title: Nicotiana benthamiana as a potential source for producing anti-dengue virus D54 neutralizing therapeutic antibody
    Authors: S. Krittanai, K. Rattanapisit, C.J.I. Bulaon, R. Strasser, W. Phoolcharoen
    Year: 2024

 

  1. Title: Associations of effort-reward imbalance at work and quality of life among workers after stroke: a one-year longitudinal study in Thailand
    Authors: S. Naknoi, J. Li, P. Ramasoota, N. Soonthornworasiri, O. Kaewboonchoo
    Year: 2023

 

  1. Title: Potential Protective Effect of Dengue NS1 Human Monoclonal Antibodies against Dengue and Zika Virus Infections
    Authors: R. Sootichote, W. Puangmanee, S. Benjathummarak, P. Ramasoota, P. Pitaksajjakul
    Year: 2023

 

  1. Title: A replication competent luciferase-secreting DENV2 reporter for sero-epidemiological surveillance of neutralizing and enhancing antibodies
    Authors: K. Saipin, B.K. Thaisomboonsuk, B. Siridechadilok, N. Sittisombut, J. Junjhon
    Year: 2022

 

  1. Title: Spread of a Novel Indian Ocean Lineage Carrying E1‐K211E/E2‐V264A of Chikungunya Virus East/Central/South African Genotype across the Indian Subcontinent, Southeast Asia, and Eastern Africa
    Authors: J. Phadungsombat, H.A. Imad, E.E. Nakayama, W. Piyaphanee, T. Shioda
    Year: 2022

 

🎯 Conclusion

Dr. Ramasoota’s work has not only advanced scientific knowledge but also contributed to real-world solutions in disease treatment and diagnostics. His collaborations with industries and commitment to innovation ensure that his research continues to benefit global health. As he continues to push the boundaries of antibody research and anti-aging science, his legacy will inspire future generations of scientists, leaving a lasting impact on virology, immunotherapy, and biotechnology.

 

Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Prof. Shilin Luo, Xiangya Hospital, Central South University, China.

Dr. Shilin Luo is a leading expert in neuropharmacology and medicinal chemistry, with a strong academic background in traditional Chinese medicine and modern pharmacology. His research focuses on the pathogenesis of neurodegenerative diseases and the development of innovative drug therapies. Through his work at Xiangya Hospital, Central South University, and previous research at Emory University, he has made significant contributions to understanding neurological disorders. His studies on animal models and risk genes have paved the way for novel treatment strategies, earning him international recognition.

Profile

Scopus

Orcid

 

🎓 Early Academic Pursuits

Dr. Shilin Luo’s journey into the world of medical science began with a deep-rooted passion for understanding the complexities of neurological diseases. He earned his Bachelor’s degree in Chinese Materia Medica from Shenyang Pharmaceutical University, where he developed a strong foundation in traditional Chinese medicine and pharmacology. With an insatiable thirst for knowledge, he further pursued a Ph.D. in Medicinal Chemistry at China Pharmaceutical University, specializing in the research of active ingredients in natural products. Under the mentorship of Prof. Wencai Ye, a distinguished scholar, Dr. Luo honed his expertise in medicinal chemistry, paving the way for groundbreaking discoveries in neuropharmacology.

👨‍🎓 Professional Endeavors

To deepen his expertise, Dr. Luo embarked on postdoctoral research at Emory University’s School of Medicine in the Department of Pathology and Laboratory Medicine. Working under the esteemed Prof. Keqiang Ye, he focused on neurobiology and neuropharmacology, contributing significantly to the understanding of neurodegenerative diseases. His research provided novel insights into the molecular mechanisms underlying neurological disorders, positioning him as a leading figure in the field. He later took on a pivotal role as a professor in the Department of Neurology at Xiangya Hospital, Central South University, where he continues to mentor young scientists and advance medical research.

🧪 Contributions and Research Focus

Dr. Luo’s research is primarily dedicated to uncovering the pathogenesis of neurodegenerative diseases and developing therapeutic interventions. His work in animal models of pathogenic and risk genes for neurological disorders has been instrumental in identifying potential drug targets. By integrating traditional Chinese medicine with modern pharmacology, he has contributed to the development of innovative neuroprotective agents. His studies on the molecular mechanisms of neuronal degeneration have led to promising advancements in combating conditions such as Alzheimer’s and Parkinson’s disease.

🏆 Accolades and Recognition

Throughout his career, Dr. Luo has been widely recognized for his groundbreaking contributions to neuropharmacology. His research has been published in high-impact scientific journals, earning him international acclaim. His dedication to scientific excellence has garnered prestigious awards, and he is frequently invited to deliver keynote lectures at global conferences. His work continues to inspire fellow researchers, solidifying his reputation as a distinguished scientist in neurological drug development.

🏰 Impact and Influence

Dr. Luo’s impact extends beyond the laboratory, as he actively contributes to the medical community through mentorship and collaboration. His efforts in integrating traditional Chinese medicinal principles with cutting-edge pharmacological approaches have opened new avenues for drug discovery. His research findings have not only influenced academic discourse but have also laid the groundwork for potential clinical applications, bringing hope to patients suffering from neurodegenerative diseases.

⚛️ Legacy and Future Contributions

As a visionary scientist, Dr. Luo continues to push the boundaries of neurological research. His commitment to translational medicine aims to bridge the gap between laboratory discoveries and clinical applications. By fostering interdisciplinary collaborations and mentoring the next generation of researchers, he is shaping the future of neuropharmacology.

 

Publication

  • Disease-modifying therapies for Alzheimer’s disease: Clinical trial progress and opportunity
    Authors: Yujie Zhang, Jie Chen, Yanru Li, Bin Jiao, Shilin Luo
    Year: 2025

 

  • The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential
    Authors: Ruiling Xu, Yuxuan Zhang, Shurui Chen, Yaohui Zeng, Xuan Fu, Ti Chen, Shilin Luo, Xiaojie Zhang
    Year: 2023

 

  • Nonviral delivery systems for antisense oligonucleotide therapeutics
    Authors: Si Huang, Xin-Yan Hao, Yong-Jiang Li, Jun‑Yong Wu, Da-Xiong Xiang, Shilin Luo
    Year: 2022

 

  • The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid‐β by microglia
    Authors: Si Huang, Xiaoli Liao, Junyong Wu, Xiaojie Zhang, Yamin Li, Daxiong Xiang, Shilin Luo
    Year: 2022

 

  • Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
    Authors: Not explicitly listed
    Year: 2021

 

  • Polygonatum sibiricum Polysaccharides Protect against MPP‐Induced Neurotoxicity via the Akt/mTOR and Nrf2 Pathways
    Authors: Si Huang, Haiyan Yuan, Wenqun Li, Xinyi Liu, Xiaojie Zhang, Daxiong Xiang, Shilin Luo, Guodong Zhang
    Year: 2021

 

  • Bushen-Tiansui Formula Improves Cognitive Functions in an Aβ1–42 Fibril-Infused Rat Model of Alzheimer’s Disease
    Authors: Chenxia Sheng, Panpan Xu, Xinyi Liu, Weijun Peng, Daxiong Xiang, Shilin Luo
    Year: 2020

 

  • Osteogenesis activity of isocoumarin a through the activation of the PI3K-Akt/Erk cascade-activated BMP/RUNX2 signaling pathway
    Authors: Not explicitly listed
    Year: 2019

 

  • Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson’s Disease
    Authors: Shilin Luo, Seong Su Kang, Zhi-Hao Wang, Xia Liu, Julia X Day, Zhiping Wu, Junmin Peng, Daxiong Xiang, Wolfdieter Springer, Keqiang Ye
    Year: 2019

 

  • Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile
    Authors: Not explicitly listed
    Year: 2018

 

Conclusion

Dr. Luo’s unwavering dedication to neurological research continues to shape the future of neuropharmacology. His innovative approach, combining traditional medicinal insights with modern scientific advancements, has the potential to revolutionize drug development for neurodegenerative diseases. As a mentor, researcher, and pioneer in his field, his contributions will leave a lasting impact on both academia and clinical medicine, offering hope for more effective treatments in the years to come.

 

Hiroshi Yamada | Neuroscience | Excellence in Innovation

Published on by Neuroscientists

Mr. Hiroshi Yamada | Neuroscience | Excellence in Innovation

Mr. Hiroshi Yamada, Medical/Tsukuba, Japan.

H. Yamada, born in Kasugai, Aichi, Japan, has built an impressive academic and professional career in neuroscience. After earning his Bachelor of Science from Tohoku University, he pursued a Master’s degree at Osaka University and later obtained his Ph.D. from Kyoto Prefectural University of Medicine. His research journey took him from postdoctoral studies in Japan to New York University, where he collaborated with renowned neuroscientist Paul W. Glimcher. Returning to Japan, he served as Section Chief at the National Center of Neurology and Psychiatry before joining the University of Tsukuba, where he progressed from Assistant Professor to Associate Professor. His research focuses on neural mechanisms, contributing significantly to neuroscience through both theoretical and practical advancements.

Profile

Google Scholar

🎓 Early Academic Pursuits

H. Yamada’s academic journey reflects a deep-rooted passion for science and medicine. Born on September 9, 1977, in Kasugai, Aichi, Japan, he pursued a Bachelor of Science degree from the Faculty of Science at Tohoku University, graduating in 2000. Driven by a desire to deepen his understanding of human biology, he earned his Master of Arts from the Faculty of Medicine at Osaka University in 2002. His academic pursuits culminated in a Ph.D. from the Graduate School of Kyoto Prefectural University of Medicine in 2005, where he laid the groundwork for his future research in neuroscience.

🧠 Professional Endeavors in Neuroscience

H. Yamada’s professional career began with postdoctoral research at Kyoto Prefectural University of Medicine under the mentorship of Minoru Kimura, focusing on advanced neurological studies. His pursuit of global scientific exposure led him to New York University in 2008, where he worked with renowned neuroscientist Paul W. Glimcher. Upon returning to Japan, Yamada took on a leadership role as Section Chief at the National Center of Neurology and Psychiatry, National Institute of Neuroscience, from 2011. This role was pivotal in shaping his expertise in neurological research, ultimately leading to his tenure as Assistant Professor at the University of Tsukuba in 2013, and later as Associate Professor in 2022.

🔬 Contributions and Research Focus

Throughout his career, H. Yamada has been dedicated to unraveling the complexities of the human brain. His research primarily focuses on neuroscience, exploring neural mechanisms underlying behavior and cognition. At the University of Tsukuba, he has contributed significantly to the understanding of brain functions, merging experimental data with theoretical models to advance the field. His collaborations with international experts have enriched his approach, making his work both diverse and impactful.

🏅 Accolades and Recognition

Yamada’s contributions to neuroscience have earned him recognition within the academic community. His leadership roles and tenured position at the University of Tsukuba reflect his outstanding research and teaching capabilities. His work at prestigious institutions like New York University and the National Center of Neurology and Psychiatry has further solidified his reputation as a respected neuroscientist, contributing to both national and international scientific advancements.

🌍 Impact and Influence

H. Yamada’s research has had a profound impact on the field of neuroscience, influencing both academic circles and clinical practices. His studies on neural behavior have provided insights that bridge the gap between theoretical neuroscience and practical applications, aiding in the development of treatments for neurological disorders. As an educator, he has mentored numerous students, fostering the next generation of neuroscientists.

🚀 Legacy and Future Contributions

Looking ahead, H. Yamada is committed to expanding the horizons of neuroscience through innovative research and global collaborations. His legacy is not only reflected in his published work but also in the students and researchers he has inspired. As he continues his journey at the University of Tsukuba, his focus remains on advancing scientific knowledge and contributing to the global understanding of the human brain.

💡 A Lifelong Dedication to Science

H. Yamada’s life is a testament to the power of curiosity and dedication. From his early academic days in Tohoku to his current role as an Associate Professor, he has consistently pursued excellence in neuroscience. His journey underscores the importance of interdisciplinary research, mentorship, and the relentless quest for knowledge, leaving a lasting mark on the scientific community.

Publication

  • Title: Tonically active neurons in the primate caudate nucleus and putamen differentially encode instructed motivational outcomes of action
    Authors: H. Yamada, N. Matsumoto, M. Kimura
    Year: 2004

 

  • Title: Roles of the lateral habenula and anterior cingulate cortex in negative outcome monitoring and behavioral adjustment in nonhuman primates
    Authors: T. Kawai, H. Yamada, N. Sato, M. Takada, M. Matsumoto
    Year: 2015

 

  • Title: Thirst-dependent risk preferences in monkeys identify a primitive form of wealth
    Authors: H. Yamada, A. Tymula, K. Louie, P.W. Glimcher
    Year: 2013

 

  • Title: Juxtacellular labeling of tonically active neurons and phasically active neurons in the rat striatum
    Authors: H. Inokawa, H. Yamada, N. Matsumoto, M. Muranishi, M. Kimura
    Year: 2010

 

  • Title: Free choice shapes normalized value signals in medial orbitofrontal cortex
    Authors: H. Yamada, K. Louie, A. Tymula, P.W. Glimcher
    Year: 2018

 

  • Title: Tonically active neurons in the striatum encode motivational contexts of action
    Authors: M. Kimura, H. Yamada, N. Matsumoto
    Year: 2003

 

  • Title: Tonic firing mode of midbrain dopamine neurons continuously tracks reward values changing moment-by-moment
    Authors: Y. Wang, O. Toyoshima, J. Kunimatsu, H. Yamada, M. Matsumoto
    Year: 2021

 

  • Title: Roles of centromedian parafascicular nuclei of thalamus and cholinergic interneurons in the dorsal striatum in associative learning of environmental events
    Authors: K. Yamanaka, Y. Hori, T. Minamimoto, H. Yamada, N. Matsumoto, et al.
    Year: 2018

 

  • Title: Inactivation of the putamen selectively impairs reward history-based action selection
    Authors: M. Muranishi, H. Inokawa, H. Yamada, Y. Ueda, N. Matsumoto, M. Nakagawa, et al.
    Year: 2011

 

  • Title: Goal-directed, serial and synchronous activation of neurons in the primate striatum
    Authors: M. Kimura, N. Matsumoto, K. Okahashi, Y. Ueda, T. Satoh, T. Minamimoto, et al.
    Year: 2003

 

Conclusion

H. Yamada’s career is a reflection of his dedication to advancing the understanding of the human brain. His academic achievements, leadership roles, and research contributions have left a lasting impact on the neuroscience community. As he continues his work at the University of Tsukuba, his legacy is defined not only by his scientific discoveries but also by his mentorship and influence on future generations of researchers. His journey stands as an inspiring example of the pursuit of knowledge and the transformative power of science.

Nawal Al-Subaie | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assist Prof Dr. Nawal Al-Subaie | Clinical Neuroscience | Best Researcher Award

Assist Prof Dr. Nawal Al-Subaie,  Princess Noura University, Saudi Arabia

Nawal Al Subaie is a dedicated Clinical Pharmacist with extensive experience in clinical and academic roles at esteemed institutions, including Prince Sultan Military Medical City (PSMMC) and Princess Noura University (PNU). She holds a PhD in Clinical Pharmacy from DMU, UK, and a Master’s in International Practice and Policy from UCL, London. With a career spanning leadership, clinical care, and education, she has made significant contributions to pharmacy practice, quality control, and chronic disease management. Her commitment to continuous learning is reflected in numerous specialized courses and symposiums, along with frequent contributions to global conferences.

 

profile

scholor

🎓 Educational Background

PhD in Clinical Pharmacy,DMU Leicester, United Kingdom.MSc in Clinical Pharmacy (International Practice and Policy)
,UCL School of Pharmacy, London, United Kingdom.Bachelor’s Degree in Hospital Pharmacy,King Saud University, Riyadh, Saudi Arabia.

💼 Working Experience

Deputy in Charge of Pharmacy Division.Family and Community Medicine.Lead Pharmacist. Wazarat Health Centre (WHC).Clinical Pharmacist,Chronic Disease Clinic, WHC.Clinical Instructor / Trainer,Continuous education for pharmacy students at King Saud University, Princess Noura University, Northern Border University.Quality Control Representative Pharmacy, WHC.Part-time Lecturer,Clinical Ocular Pharmacology, King Saud University.JCI Accreditation Awardee,Primary Care Team.In-Charge of Clinical Pharmacist Ambulatory Care Clinics, PSMMC, 2020–2022.Assistant Professor,Princess Noura University (PNU), May 2022 – Present.

🏫 Training Courses / Symposiums

2015 – 2019: PhD Student (Diabetes and Exercise)Pharmacy School, DMU, UK.2014: TOT Course Leicester, UK.2016: Phlebotomy Course Nottingham, UK.2016: First Aid CourseLeicester, UK.2022: ASHP Diabetes Management Certificate Course January – December 2022.

🌍 Conferences Attended & Contributions

2024: Attended the 4th Saudi Society of Clinical Pharmacist Annual International Conference (September).2024: Presented Poster at Dubai International Pharmaceuticals and Technologies Conference.2023: Oral Presentation at Neurology Conference, Dubai (March).2023: Judge, Pharmacy Research Day, PNU Research Center (May).2022: Attended First Saudi Society of Clinical Pharmacist Annual International Conference (September)(and many more from 2000 to 2024)

🤲 Voluntary Work

University orientation for new students, DMU. Diabetes Awareness Day, in collaboration with Diabetes UK. Trained students at DMU on ELISA and Randox machine for blood sample analysis. Assisted pharmacy students with projects and dissertations, DMU

🏅 Professional Memberships

Saudi Commission for Health Specialties (ID: 09-R-P-0295492)

📚 Publications

  1. Statins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review
    Authors: N. Alsubaie, H.M. Al-Kuraishy, A.I. Al-Gareeb, B. Alharbi, M. De Waard, …
    Year: 2022

 

  1. Discussing Pathologic Mechanisms of Diabetic Retinopathy & Therapeutic Potentials of Curcumin and β-glucogallin in the Management of Diabetic Retinopathy
    Authors: M. Rohilla, S. Bansal, A. Garg, S. Dhiman, S. Dhankhar, M. Saini, S. Chauhan, …
    Year: 2023

 

  1. The Potential Therapeutic Effect of Metformin in Type 2 Diabetic Patients with Severe COVID-19
    Authors: H.M. Al-Kuraishy, A.I. Al-Gareeb, A.A. El Kholy, E. El-Khateeb, A. Alexiou, …
    Year: 2023

 

  1. The Effects of a Combined Exercise Programme Aerobic and Resistance on Blood Glucose, Incretin, Metabolic and Inflammatory Mediators that Could Control the Diabetes and Improve …
    Author: N. Alsubaie
    Year: 2019

 

  1. Corrigendum to “Discussing Pathologic Mechanisms of Diabetic Retinopathy & Therapeutic Potentials of Curcumin and β-glucogallin in the Management of Diabetic Retinopathy”
    Authors: M. Rohilla, S. Bansal, A. Garg, S. Dhiman, S. Dhankhar, M. Saini, S. Chauhan, …
    Year: 2024

 

  1. Impact of Clinical Pharmacist Diabetes Clinic on the Improvement of Health Outcomes in Type 2 Diabetes Subjects
    Authors: N. AlSubaie, M. Alsallal, S. AlTwaijri, A. AlOtaibi, B. AlHarbi, M. AlEissa, …
    Year: 2022

 

  1. The Effects of a Combined Aerobic and Resistance Exercise Programme on Insulin Resistance Among Prediabetes Subjects
    Authors: B. Alharbi, N. Alsubaie, T.S. Sahota, M.J. Taylor
    Year: 2019

 

  1. The Effects of a Combined Exercise Programme (Aerobic and Resistance) on Blood Glucose and Incretin Hormone That Could Control the Diabetes in Type 2 Diabetes
    Authors: N. Alsubaie, B. Alharbi, T.S. Sahota, M.J. Taylor
    Year: 2019

 

  1. The Effects of a Combined Exercise Programme (Aerobic and Resistance) on Blood Glucose, and Incretin Hormone That Could Control the Diabetes in Type 2 Diabetes
    Authors: B.M. Alharbi, N.S. Alsubaie, T.S. Sahota, M.J. Taylor
    Year: 2019

 

  1. The Impact of Moderate Combination Exercise on HbA1c, IL-6, and TNF in Type 2 Diabetic and Non-diabetic Subjects: An Interventional Non-randomized Clinical Trial
    Authors: B. Alharbi, N. Alsubaie, T.S. Sahota, M.J. Taylor
    Year: 2019

 

 Conclusion

Dr. Al Subaie’s career showcases a deep commitment to enhancing patient care, advancing pharmaceutical education, and contributing to international health discussions. Her background in both hands-on clinical care and academic research equips her with a well-rounded perspective, making her a valuable asset in clinical and educational settings alike. She continues to make strides in diabetes management, chronic disease care, and pharmacy education, with her work recognized through multiple presentations, awards, and professional memberships.

 

 

Hamid khan | Molecular and Cellular Neuroscience | Young Scientist Award

Published on by Neuroscientists

Mr.Hamid khan | Molecular and Cellular Neuroscience | Young Scientist Award

Mr. Hamid khan Icahn School of Medicine at Mount Sinai, New York Pakistan

Hamid Khan is a dedicated researcher and educator who recently completed his PhD in Biotechnology, specializing in Human Molecular Genetics. His academic journey includes a strong foundation in biological sciences, evidenced by his educational background ranging from a BSc to a PhD, with a focus on genetic analysis of rare congenital disorders. His doctoral research has provided insights into the genetic basis of autism spectrum disorder (ASD) and oculocutaneous albinism, contributing significantly to the understanding of these conditions.

profile

scholar

🎓 Education

PhD in Biotechnology (Human Molecular Genetics)International Islamic University Islamabad, Pakistan & University of Toronto, Canada (2018-2024).MS/M.Phil in Biotechnology (Human Molecular Genetics)International Islamic University Islamabad, Pakistan (2016-2018).M.Sc in ZoologyHazara University Mansehra, KPK, Pakistan (2011-2013).B.Sc in Biological Science (Botany, Zoology, Chemistry)University of Peshawar, Pakistan (2008-2010).H.S.S.C Pre-Medical
Peshawar Board, Pakistan (2006-2008)S.S.C Science SubjectsPeshawar Board, Pakistan (2004-2006).B.Ed in Education
Sarhad University of Science & Information Technology (2014).CT Certified TeacherAllama Iqbal Open University (2016).

🔬 Research Experience

Researcher at Biomolecular Genetic Engineering Lab, International Islamic University Islamabad (4 years).Research Associate in Pak-US Science and Technology Cooperation Program (1 year).Researcher in MiND Laboratory, Campbell Family Mental Health Research Institute, Toronto, Canada (6 months)

💼 Work Experience

Visiting Lecturer at Department of Biological Sciences, IIUI (3 years).Lecturer at IQRA College of Technology, IIUI (2 years)

 

🛠️ Skills

Laboratory Skills: PCR, NGS data analysis, Microarray, Gene Cloning, Cell Culturing, etc.Computer Skills: Python, Sentieon, Verseq, Exomiser, Excel, PowerPoint, Word.

🏆 Awards

IRSIP Award from the Higher Education Commission (HEC) Pakistan.First position holder in PhD coursework.Selected as Research Associate in a Pak-US project.

🌍 Collaborations

Currently working with three international and several national collaborations.

📚 Publications

  1. Title: Biallelic variants identified in 36 Pakistani families and trios with autism spectrum disorder
    Authors: Hamid Khan, Ricardo Harripaul, Anna Mikhailov, Sumayah Herzi, …
    Year: 2024

 

  1. Title: Elucidating the clinical and genetic spectrum of inositol polyphosphate phosphatase INPP4A-related neurodevelopmental disorder
    Authors: Lettie E Rawlins, Reza Maroofian, Stuart J Cannon, Muhannad Daana, Mina Zamani, Shamsul Ghani, …
    Year: 2024

 

  1. Title: Nigella sativa extract abrogates traumatic brain injury-induced memory impairment in adult mice
    Authors: RU Khan, SM Jawad, MM Kiyani, SA Shah, S Bashir, Hamid Khan
    Year: 2024

 

  1. Title: Mutational spectrum associated with oculocutaneous albinism and Hermansky-Pudlak syndrome in nine Pakistani families
    Authors: J Khan, S Asif, S Ghani, Hamid Khan, MW Arshad, SA Khan, S Lin, EL Baple, …
    Year: 2024

 

  1. Title: An Update on Recent Advancement in Autism Spectrum Disorder Treatment Strategies
    Authors: Hamid Khan, M Uzair, H Riaz, B Khan, MI Shabbir
    Year: 2023

Conclusion

Hamid Khan’s profile illustrates a strong commitment to advancing the field of biotechnology through research and education. His focus on the genetic underpinnings of rare disorders positions him as a valuable contributor to both academic and clinical settings. With a proven track record of research publications and collaborative projects, he is poised to make significant impacts in the realm of human genetics and molecular biology. His dedication to teaching and nurturing student curiosity further underscores his potential as an educator and mentor. As he seeks new opportunities, his combination of technical expertise, research experience, and passion for education will undoubtedly enable him to excel and inspire in any dynamic academic or research environment.